Background. Retrospective studies have suggested an association between cancer-
associated venous thromboembolism (VTE) and patient survival. We evaluated a previously …

Retrospective population-based studies showed that in cancer patients venous
thromboembolism (VTE) is associated with reduced survival. Master Oncology is a …

Purpose Patients with cancer are increasingly at risk for venous thromboembolism (VTE).
Rates of VTE, however, vary markedly among patients with cancer. Design This review …

Venous thromboembolism (VTE) is a significant cause of morbidity and mortality in patients
with cancer. The risk of VTE varies over the natural history of cancer, with the highest risk …

Venous thromboembolism (VTE) is common in cancer patients, and is associated with
significant morbidity and mortality. Several factors, including procoagulant agents secreted …

Nearly 20% of all venous thromboembolism (VTE) occurs in cancer patients, and as many
as 78% of cancer patients who develop a thrombotic event do so as outpatients. The risk of …

The incidence of venous thromboembolism (VTE) is known to be higher in patients with
malignancy as compared with the general population. It is important to understand and …

Although cancer is recognized as a major risk factor for venous thromboembolism, the exact
magnitude of the problem and specific risk factors most strongly associated with the …

Current guidelines recommend that patients with cancer be assessed for venous
thromboembolism (VTE) risk at the time of chemotherapy initiation and periodically …

BACKGROUND: Recent studies suggest that thromboprophylaxis is beneficial in preventing
venous thromboembolism (VTE) in cancer outpatients, but this is not widely adopted …